Optimum Investment Advisors’s Neuronetics STIM Stock Holding History

Optimum Investment Advisors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$546	Hold	200	–	–	﹤0.01%	592
2025 Q2	$698	Hold	200	–	–	﹤0.01%	593
2025 Q1	$736	Hold	200	–	–	﹤0.01%	618
2024 Q4	$322	Hold	200	–	–	﹤0.01%	607
2024 Q3	$152	Hold	200	–	–	﹤0.01%	629
2024 Q2	$360	Hold	200	–	–	﹤0.01%	624
2024 Q1	$952	Hold	200	–	–	﹤0.01%	617
2023 Q4	$580	Hold	200	–	–	﹤0.01%	615
2023 Q3	$270	Hold	200	–	–	﹤0.01%	693
2023 Q2	$430	Hold	200	–	–	﹤0.01%	685
2023 Q1	$582	Hold	200	–	–	﹤0.01%	707
2022 Q4	$1.37K	Hold	200	–	–	﹤0.01%	698
2022 Q3	$1K	Hold	200	–	–	﹤0.01%	786
2022 Q2	$1K	Sell	200 -800	-80%	-$2.32K	﹤0.01%	805
2022 Q1	$3K	Hold	1,000	–	–	﹤0.01%	773
2021 Q4	$4K	Hold	1,000	–	–	﹤0.01%	752
2021 Q3	$7K	Hold	1,000	–	–	﹤0.01%	718
2021 Q2	$16K	Buy	1,000 +800	+400%	+$11.1K	0.01%	701
2021 Q1	$2K	Hold	200	–	–	﹤0.01%	873
2020 Q4	$2K	Hold	200	–	–	﹤0.01%	836
2020 Q3	$1K	Buy	+200	New	+$759	﹤0.01%	857

Other funds holding STIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Optimum Investment Advisors's STIM Position: Q3 2025 in Review

Optimum Investment Advisors held its Neuronetics (STIM) position steady in Q3 2025 at 200 shares worth $546. The position accounts for ﹤0.01% of the portfolio, ranked #592.

Optimum Investment Advisors first reported a position in STIM in Q3 2020 and has held it in 21 quarters since. The position peaked at $16K in Q2 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q3 2025.

Optimum Investment Advisors held 200 shares of Neuronetics worth $546 as of Q3 2025.
Optimum Investment Advisors left its Neuronetics share count unchanged in Q3 2025.
Neuronetics made up ﹤0.01% of Optimum Investment Advisors's portfolio in Q3 2025, its #592 holding.
Optimum Investment Advisors first reported a position in Neuronetics in Q3 2020 and has held it in 21 quarters since.
Optimum Investment Advisors's Neuronetics position peaked at $16K in Q2 2021.
99 funds tracked by Wall St. Rank held Neuronetics as of Q3 2025.

Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.